An aptamer-based electrochemical sensor for the quantification of the malaria biomarker lactate dehydrogenase
Abstract
Malaria is one of the most deadly infectious diseases, causing the death of hundreds of thousands of patients each year. Global efforts to combat malaria necessitate the implementation of novel rapid diagnostic tests deployable at the point of care. Here, we present the development of an electrochemical aptamer-based (EAB) sensor for the quantification of the malaria biomarker Plasmodium falciparum lactate dehydrogenase (PfLDH). Specifically, we demonstrate how, through careful optical and electrochemical characterization, we re-engineered the aptamer sequence to maximize its binding-induced conformational change, the core principle of EAB sensors. We then demonstrated that our biosensor can quantify clinically relevant concentrations of PfLDH in blood in a single step and within a few minutes. Overall, we believe these results demonstrate the promising potential of EAB sensors for the diagnosis and prognosis of malaria at the point of care.
Read the paper
Related studies
- Nano Biosensors: Properties, applications and electrochemical techniques
- Electrochemically Synthesized MIP Sensors: Applications in Healthcare Diagnostics
- Toward a Harmonization for Using in situ Nutrient Sensors in the Marine Environment
- Electrochemical determination of rutin by using NiFe2O4 nanoparticles-loaded reduced graphene oxide
- Application of Polyoxometalate-based composites for sensor systems: A review
- Sensitive Electrochemical and Thermal Detection of Human Noroviruses Using Molecularly Imprinted Polymer Nanoparticles Generated against a Viral Target
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.